Transcranial Magnetic Stimulation (TMS) Therapy
NEW: TMS is now covered by these insurers:
- Blue Cross Blue Shield
Transcranial Magnetic Stimulation is offered by Philip Schlobohm, MD, a Board Certified psychiatrist who has been working with Riverside since 2002.
Transcranial Magnetic Stimulation (TMS) was approved by the FDA in 2008 as a treatment for Treatment-Resistant Depression. The FDA also approved the NeuroStar TMS System which to date is the only FDA approved device and the system that Riverside utilizes.
Potential candidates for this treatment must have failed at least one complete therapeutic trial of an anti-depressant and must have moderate to severe depression as determined during the evaluation by a psychiatrist.
About the treatment
TMS is a non-invasive procedure that is performed on an out-patient basis while the patient is fully awake. Many actually sleep during the procedure.atients experience a tapping sensation on their scalp beneath the treatment head for approximately 37 – 40 minutes after which the patient returns home. During a treatment, a MRI equivalent magnetic field is produced which stimulates areas of the brain that are associated with depression. A full course of treatment consists of daily treatment for 5-6 weeks.
Last November, TMS was upgraded to the Standard of Care for Treatment-Resistant-Depression by being granted a regular, standard CPT Code. This state-of-the-art treatment is presently being given at Riverside Behavioral Health Center by Philip Schlobohm, M.D., a Board Certified psychiatrist who has been working with Riverside since 2002.